Tariq Musa 4

What Happened

• Tariq Musa, a director of Guardant Health (GH), converted/ exercised 250 restricted-stock-unit–derived shares on 2026-04-15 (reported as derivative exercise/conversion, code M) and had a simultaneous derivative disposition of 250 shares (also listed under code M) at $0.00. He then sold 116 shares in the open market on 2026-04-16 at $84.83 per share for total proceeds of $9,840. The RSU conversion indicates vested awards were turned into shares; the subsequent open-market sale is a sale (not a purchase).

Key Details

• Transaction dates and prices:
  • 2026-04-15: Exercise/conversion of derivative — 250 shares acquired @ $0.00 (code M)
  • 2026-04-15: Derivative disposition — 250 shares disposed @ $0.00 (code M)
  • 2026-04-16: Open-market sale — 116 shares @ $84.83 = $9,840 (code S)
• Shares owned after transaction: Not reported in the provided filing excerpt.
• Footnotes: F1 — RSU award granted Mar 6, 2023 vests over four years (25% vested Mar 15, 2024; remaining 75% vests monthly over the next three years). F2 — Not applicable for Restricted Stock Units.
• Filing timeliness: Report filed Apr 16, 2026 for transactions dated Apr 15–16, 2026 (appears timely).

Context

• The M code indicates conversion/exercise of derivative securities (here, RSUs vesting into shares). The filing shows shares converted and a small open-market sale; this is a routine insider sale rather than a purchase (which can be taken as a stronger bullish signal). The cash value of the reported open-market sale is modest (~$9.8K).